Industry

Pharmaceuticals

Developers of branded and generic drugs. Value creation rests on R&D pipelines, patent lifecycles, regulatory approvals and pricing power versus payers.

Total Companies
1 270
Company Intrinsic Valuation Profitability Score Solvency Score Market Cap
Eli Lilly and Co
NYSE:LLY
Loading...
53% Overvalued
72 / 100
64 / 100
$731.4B
Dechra Pharmaceuticals PLC
LSE:DPH
Loading...
N/A
43 / 100
52 / 100
$589.9B
Johnson & Johnson
NYSE:JNJ
Loading...
2% Undervalued
62 / 100
55 / 100
$373.3B
Novo Nordisk A/S
CSE:NOVO B
Loading...
32% Undervalued
78 / 100
72 / 100
$299B
Roche Holding AG
SIX:ROG
Loading...
9% Undervalued
63 / 100
65 / 100
$253.1B
Novartis AG
SIX:NOVN
Loading...
4% Overvalued
64 / 100
63 / 100
$234.8B
AstraZeneca PLC
LSE:AZN
Loading...
29% Undervalued
61 / 100
47 / 100
$218B
Merck & Co Inc
NYSE:MRK
Loading...
33% Undervalued
64 / 100
65 / 100
$205.1B
Pfizer Inc
NYSE:PFE
Loading...
14% Undervalued
52 / 100
44 / 100
$139.9B
Sanofi SA
PAR:SAN
Loading...
7% Undervalued
57 / 100
49 / 100
$120.3B
Bristol-Myers Squibb Co
NYSE:BMY
Loading...
34% Undervalued
59 / 100
37 / 100
$94.5B
GlaxoSmithKline PLC
LSE:GSK
Loading...
28% Undervalued
64 / 100
46 / 100
$77.9B
Chugai Pharmaceutical Co Ltd
TSE:4519
Loading...
36% Overvalued
70 / 100
99 / 100
$75.7B
Zoetis Inc
NYSE:ZTS
Loading...
20% Overvalued
71 / 100
62 / 100
$68.2B
Merck KGaA
XETRA:MRK
Loading...
33% Undervalued
51 / 100
58 / 100
$55.5B
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Loading...
26% Overvalued
63 / 100
87 / 100
$51B
A
Aspen Pharmacare Holdings Ltd
JSE:APN
Loading...
N/A
48 / 100
48 / 100
$50.1B
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Loading...
28% Overvalued
60 / 100
97 / 100
$47.7B
Takeda Pharmaceutical Co Ltd
TSE:4502
Loading...
10% Undervalued
46 / 100
35 / 100
$47B
Daiichi Sankyo Co Ltd
TSE:4568
Loading...
35% Undervalued
59 / 100
86 / 100
$42.8B
Load More